ArriVent BioPharma, Inc. (AVBP) Misses Q2 EPS by 14c

ArriVent BioPharma, Inc. (NASDAQ: AVBP) reported Q2 EPS of ($0.90), $0.14 worse than the analyst estimate of ($0.76).

For earnings history and earnings-related data on ArriVent BioPharma, Inc. (AVBP) click here.

You May Also Be Interested In

• Tesla to launch Cybercab in Austin this month - report
• Wendy's U.S. president to resign, company to create COO role
• Duos Technologies Group, Inc. (DUOT) Tops Q2 EPS by 163c